1. Home
  2. Recombinant Proteins and Antibody Research Tools
  3. SARS-CoV-2 Recombinant Proteins
  4. SARS-CoV-2 full-length Trimeric Spike Antigen B.1.617 Mutation (Indian Kappa Variant) (100 μg)

SARS-CoV-2 full-length Trimeric Spike Antigen B.1.617 Mutation (Indian Kappa Variant) (100 μg)

£490.00

100 μg

100μl buffer solution with 0.001% LMNG provided separately FREE OF CHARGE
SKU: BSV-COV-PR-92

SARS-CoV-2 Spike Antigen B.1.617 (Kappa Variant)

All viruses undergo fast mutations and adept quickly to the countermeasures that the immune systems creates against them. SARS-CoV-2 of the COVID-19 pandemic is no exception here. During the pandemic multiple mutant strains arose. Spike protein of the mutant strain B.1.617 is a full-length protein, which is active in its native trimeric form, that is stabilized in LMNG detergent.

Kappa Variant Features

Product Name: SARS-CoV-2 full-length Trimeric Spike Recombinant Antigen B.1.617 Variant
UniProt Number: P0DTC2
Mutations that differ from SPIKE protein: G142D, E154K, L452R, E484Q, D614G, P681R, Q1071H
Host: HEK293
Buffer Composition: 20 mM Hepes pH 7.5; 150 mM NaCl, 0.001% LMNG
Molecular Weight (Trimeric): 3 x 142 kDa = 426 kDa

Menu